0000000000010417

AUTHOR

Pablo Vega

showing 7 related works from this author

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

2021

Abstract Background and Aims The development programm UNIFI has shown promising results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in clinical practice. We aimed to evaluate the durability, effectiveness, and safety of ustekinumab in UC in real life. Methods Patients included in the prospectively maintained ENEIDA registry, who received at least one intravenous dose of ustekinumab due to active UC [Partial Mayo Score [PMS]>2], were included. Clinical activity and effectiveness were defined based on PMS. Short-term response was assessed at Week 16. Results A total of 95 patients were included. At Week 16, 53% of patients had response [including 35% o…

Malemedicine.medical_specialtyustekinumabVedolizumab03 medical and health sciences0302 clinical medicineremissionColitis ulcerosaInternal medicineUstekinumabHumansMedicineProspective StudiesRegistriesInfusions IntravenousAdverse effectreal-world evidenceAcademicSubjects/MED00260ulcerative colitisTofacitinibresponsebiologybusiness.industryRemission InductionC-reactive proteinGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisDiscontinuation030220 oncology & carcinogenesisCohortbiology.proteindurabilityOriginal ArticleColitis UlcerativeFemaleMonoclonal antibodies030211 gastroenterology & hepatologyUstekinumabbusinessAnticossos monoclonalsmedicine.drug
researchProduct

Hepatitis C Crónica y usuarios con un historial de inyección de drogas en España: evaluación de la población, retos para un tratamiento efectivo.

2017

La hepatitis C cronica (HCC) es una enfermedad de desigualdad que afecta desproporcionadamente a las personas desatendidas por la salud publica. Personas con antecedentes de uso de opioides o uso de drogas por via parenteral (UDVP) se enfrentan a desigualdad y estigma. Un historia previa de inyeccion de drogas es un comportamiento que incrementa el riesgo de contraer el VHC. Hay una gran incidencia de HCC entre las personas se inyectan drogas. Hay mas de 300,000 personas en Espana que actualmente se inyectan drogas o tienen antecedentes. Hay 150,000 personas en Espana con un historial trastorno de uso de opioides y la mayoria son UDVP o ex UDVP. Aproximadamente 80,000 personas usan los serv…

Hepatitis C -- Tractament03 medical and health sciencesPsychiatry and Mental health0302 clinical medicine030220 oncology & carcinogenesisPhilosophyTreatment outcomeDrogoaddiccióMedicine (miscellaneous)030211 gastroenterology & hepatologyHumanitiesAdicciones
researchProduct

Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.

2017

Producción Científica

medicine.medical_specialtylcsh:RC435-571Alcohol use disorderReviewTrastorno de ansiedadTrastorno por consumo de alcoholco-occurring disorders03 medical and health sciences0302 clinical medicinePrevalence of mental disordersanxiety disorderslcsh:Psychiatrymental disordersmedicinePsychiatryPsychiatrySertralineSocial anxietyAlcohol dependencealcohol-use disorderComorbilidadmedicine.diseaseParoxetineComorbidity030227 psychiatryPsychiatry and Mental healthcomorbiditytreatment recommendationsTrastornos concurrentesPsychology030217 neurology & neurosurgeryAnxiety disordermedicine.drugClinical psychology
researchProduct

Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad …

2018

Resumen Objetivos Establecer recomendaciones para el manejo de los aspectos psicologicos de los pacientes con enfermedad inflamatoria intestinal (EII). Metodos Se llevo a cabo una reunion con un grupo de expertos en EII formado por medicos, psicologos, enfermeras y representantes de pacientes. Se presentaron resultados de: 1) un grupo focal previo, 2) encuestas a medicos y pacientes y 3) una revision sistematica sobre instrumentos de cribado de ansiedad y depresion. Se realizo una discusion guiada sobre los aspectos psicologicos y emocionales mas importantes en EII, los criterios de derivacion apropiados y situaciones a evitar. Se selecciono el instrumento validado mas aplicable a la practi…

03 medical and health sciences0302 clinical medicineHepatologybusiness.industry030220 oncology & carcinogenesisGastroenterologyMedicine030211 gastroenterology & hepatologybusinessHumanitiesGastroenterología y Hepatología
researchProduct

Rethinking Dual Disorders/Pathology

2013

Objective:Comorbidity of addictive disorders and other psychiatric disorders is very common. The optimal treatment of patients with addiction disorders requires awareness of their comorbid mental disorders and vice versa. The operational and contextual definitions of the different terms used vary si

Pathologymedicine.medical_specialtybusiness.industryOptimal treatmentAddictionmedia_common.quotation_subjectMedicine (miscellaneous)DUAL (cognitive architecture)medicine.diseaseComorbidityPsychiatry and Mental healthPsychiatric comorbiditymental disordersMedicinebusinessmedia_commonAddictive Disorders & Their Treatment
researchProduct

Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals

2014

Since provision of integrated services for patients with dual pathology or dual disorders (coexistence of an addictive disorder and another mental health disorder) is an important challenge in mental health, this study assessed health care professionals' perceptions and knowledge of the current state of specific resources for patients with dual pathology in Spain.We conducted a national survey of health care professionals seeing patients with dual pathology in treatment facilities throughout Spain. Participants completed a specific online questionnaire about the needs of and available resources for patients with dual pathology.A total of 659 professionals, mostly psychologists (n = 286, 43.…

MaleMental Health Servicesmedicine.medical_specialtyResource (biology)Substance-Related DisordersHealth Personnelmedia_common.quotation_subjectComputer-assisted web interviewingHealth caremedicineHumansPsychiatrymedia_commonbusiness.industryData CollectionMental DisordersAddictionmedicine.diseaseMental healthSubstance abusePsychiatry and Mental healthDiagnosis Dual (Psychiatry)SpainHealth ResourcesDual diagnosisFemalebusinessJournal of Dual Diagnosis
researchProduct

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

2021

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD—Crohn’s disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)—during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and…

Crohn’s diseasemedicine.medical_specialtyPopulationDiseaseInflammatory bowel diseasedigestive systemArticle03 medical and health sciences0302 clinical medicineInterquartile rangeinflammatory bowel diseaseInternal medicineEpidemiologyMedicineeducationCrohn’s disease epidemiology incidence inflammatory bowel disease ulcerative colitisulcerative colitisCrohn's diseaseeducation.field_of_studybusiness.industryIncidence (epidemiology)RGeneral Medicinemedicine.diseaseUlcerative colitisdigestive system diseasesCrohn's disease030220 oncology & carcinogenesisincidenceMedicine030211 gastroenterology & hepatologyepidemiologybusiness
researchProduct